Nuvation Bio (NUVB) Total Debt (2020 - 2026)

Nuvation Bio (NUVB) has reported Total Debt for 3 consecutive years, with $53.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Debt rose 834.34% year-over-year to $53.1 million; the TTM figure through Mar 2026 stood at $53.1 million (up 834.34% YoY), while the FY2025 annual figure was $52.9 million, up 742.46% from the prior year.
• Total Debt was little changed at $53.1 million in Q1 2026 per NUVB's latest filing, from $52.9 million in the prior quarter.
• Across five years, Total Debt topped out at $53.1 million in Q1 2026 and bottomed at $5.7 million in Q1 2025.
• Historically, Total Debt has averaged $30.4 million across 3 years, with a median of $32.1 million in 2024.
• Annual changes were most pronounced in 2025 — Total Debt jumped 351.75% — and 2026, when it jumped 834.34%.
• Nuvation Bio's Total Debt stood at $6.3 million in 2024, then surged by 742.46% to $52.9 million in 2025, then advanced by 0.35% to $53.1 million in 2026.
• Business Quant data shows NUVB's Total Debt at $53.1 million in Q1 2026, $52.9 million in Q4 2025, and $52.7 million in Q3 2025.